Although it seems that low adiponctin in AMI is secondary to plaque rupture and inflammation but if according to previous cohort studies [14,22,28] adiponectin consider as risk factor for coronary artery disease, measurement of adiponectin levels may be helpful in the stratification of patients at risk of AMI. Here, ADIPOQ is linked to coronary artery disorder.